| 别名 | ;['5,6-Diamino-4-hydroxy-2(1', 'H', ')-pyrimidinone Sulfate Dihydrate', '5,6-Diamino-2,4-pyrimidinediol Sulfate Dihydrate', '5,6-Diaminouracil Sulfate Dihydrate'] |
5,6-二氨基-2,4-二羟基嘧啶硫酸盐二水合物
5,6-Diamino-2,4-dihydroxypyrimidine Sulfate Dihydrate （订货以英文为准）
编号：D155132
CAS号：63981-35-1
分子式：C4H6N4O2.H2O4S.2[H2O]
分子量：276.23
| 产品名称 | 5,6-Diamino-2,4-dihydroxypyrimidine Sulfate Dihydrate |
| 中文名称 | 5,6-二氨基-2,4-二羟基嘧啶硫酸盐二水合物 |
| CAS号 | 63981-35-1 |
| MDL编码 | D155132 |
| 分子式（M.F.） | C4H6N4O2.H2O4S.2[H2O] |
| 分子量（M.W.） | 276.23 |
| Reaxys-RN | 5795441 |
| 信号词 | Warning |
| 危害声明 | H302-H319 |
| 警示性声明 | P305 + P351 + P338 |
| 个人防护设备 | dust mask type N95 (US)， Eyeshields， Gloves |
| RTECS | UW0495000 |
| WGK德国 | 3 |
技术规格
| Background: | DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK2 may modulate the cellular proliferation induced by IL-4, as well as IL-2 and IL-3. May be involved in modulating Bcr-Abl signaling. Attenuates EGF-stimulated MAP kinase activation |
| Applications: | WB, IHC, IF |
| Name of antibody: | DOK2 (Phospho-Tyr299) |
| Immunogen: | Synthetic peptide of human DOK2 (Phospho-Tyr299) |
| Full name: | docking protein 2, 56kDa (Phospho-Tyr299) |
| Synonyms： | p56DOK; p56dok-2 |
| SwissProt: | O60496 |
| IHC positive control: | Human breast carcinoma |
| IHC Recommend dilution: | 50-100 |
| WB Predicted band size: | 56 kDa |
| WB Positive control: | Jurkat cells treated with insulin |
| WB Recommended dilution: | 500-1000 |
| IF Positive control: | Hela cells |
| IF Recommended dilution | 100-200 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 2140.00
RC201-50 rxns
¥ 97.20
02053450-1个
¥ 60.00
60890B-25g
¥ 50.00
jx25528148-1盒
¥ 50.00
jx25528147-1盒
党沛 
